United States
AT
AU
BE
CA
CH
CN
CZ
DE
DK
ES
FI
FR
GR
HR
HU
IE
IL
IN
IT
JP
NL
NO
PL
PT
RO
RU
SE
SK
TR
UK
ZA
Menu
Alert: Product and Recall NoticesNow Available – the Guardian Connect Smart CGM System with the Sugar.IQ diabetes assistant!
In March, we announced FDA approval of the world’s first Smart1 CGM, the Guardian Connect system. This all new continuous glucose monitor is specifically designed to provide valuable insights – right on your smartphone – so you can take action2 against highs and lows. If you inject insulin or manage diabetes with oral medication, I’m excited to announce that the Guardian Connect CGM system is available for purchase, for those who use an iOS device (Android available in the future).
Why Introduce a Smart CGM for People Using Insulin Injections? Because We Are Inspired by You!
The Guardian Connect Smart CGM was developed based on your feedback: This is why we’ve introduced the Guardian Connect Smart CGM. It’s also why we’ve partnered with IBM Watson Health (who are experts in using artificial intelligence to solve life’s everyday challenges) to develop the Sugar.IQ diabetes assistant. This first of 
its kind diabetes assistant is exclusively available with the Guardian Connect system and uses CGM information and smart algorithms to give you insights about what’s impacting your diabetes. Only with the Sugar.IQ assistant, you can see hidden patterns you’ve never noticed before, track your favorite foods to see how they affect your glucose levels3 and, just as important, you’ll receive encouragement to inspire you when things are going well. These insights empower you to manage your diabetes better than ever before and 89%4 of the people who tried the Sugar.IQ assistant liked the insights they received. We’re inspired by all people living with diabetes, wherever you are on your journey. Thousands of people worldwide have shared with us the importance of tools to help you understand your glucose and empower you to act on that information. We know people who prefer to manage diabetes with injections or pens deserve access to smart diabetes technology. Technology that provides valuable information and insights to help them make better diabetes management decisions.
A New Chapter for Medtronic
While we’re known for bringing together insulin pumps, glucose monitors and advanced algorithms to automate insulin delivery, we’re excited to enter a new chapter here at Medtronic. A chapter that provides multiple options for people living with diabetes. Depending on your needs, you and your healthcare team might decide the MiniMed 670G system, or the Guardian Connect CGM or even our i-Port Advance Injection Port is best for you. All of these options allow you to manage diabetes on your terms, which is most important. It also allows you to seamlessly switch therapies throughout your journey should you choose to do so. And, as the leader in innovation, we’re always working on what’s next to bring better technology to people living with diabetes.
What’s Next for Guardian Connect?
Even though we’ve just introduced the Guardian Connect CGM system, we’re already working on what’s next:
- Providing access for Android users is our first priority.
- We’re continuing to partner and innovate to bring even more smart tools to people with diabetes.
- We are launching a program to make it easy to transition from Guardian Connect to a MiniMed insulin pump system should you choose that path in the future.
What’s Next for Insulin Pump Systems?
We are listening to those who have chosen automated insulin delivery (i.e. the MiniMed 670G system) and want remote monitoring via smartphone as part of these systems. The Guardian Connect system is a key milestone to providing Bluetooth connectivity and smartphone access to customers using our insulin delivery systems. With Bluetooth-enabled CGM, we have one of the key components for the system, and we’re working hard to connect our insulin pumps and meters via Bluetooth as well. As we have an update we’ll let the community know. We’re also working on improvements to the system and expanding access for those interested in automated insulin delivery systems.
So, while we’re inspired by people like John and Nicky who use the MiniMed 670G system, we’re also inspired by people like Brett and Sara who choose to manage diabetes with pens and the Guardian Connect CGM system.
Our vision is to be a company for all people living with diabetes at all times throughout their journey. We’ve heard that you want to focus on your life, instead of your diabetes and we’re here to help you take one step at a time.
I personally am very honored to help you step-by-step in your journey.
1Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ insights that can inform users of clinically relevant glucose patterns.
2The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
3The system is intended to complement, not replace information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard glucose monitoring devices. All therapy adjustments should be obtained using a home blood glucose meter and not on values provided by the system.
4Medtronic data on file
5The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
698.5% low glucose detection rate based on Guardian™ Sensor 3 technology. With threshold and predictive alerts enabled within the 30 minute period before or after your blood sugar goes below 70 mg/dL.
7Users from outside of the U.S., using an earlier version of the Guardian™ Connect App. Low episode is defined as ≤70mg/dL in sensor glucose level; high episode as ≥180mg/dL in sensor glucose level.
Important Safety Information
The Guardian™ Connect System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation.
The Sugar.IQ™ Diabetes Assistant
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian Connect system through the CareLink Personal™ software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify data or control functions of the Guardian Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/download-library.
The MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library
Related Post
About Author
Editorial Team
LOOP Blog Editorial TeamAt Medtronic Diabetes our vision is to transform diabetes care together for greater freedom and better health. Each word in that statement is important – including the one “together”. We’re a group of passionate people working hard to make a big positive impact on the lives of those with diabetes. But we can’t do it alone. Collaboration is key. With healthcare providers, academic institutions, non-profits and other companies. And, most importantly, with you – the people who live with diabetes every day.
I have had the 670g closed loop system for over two years. I recently moved and changed my Medicare carrier to Humana. Imagine my surprise when I was told that they won’t pay for the Guardian 3 sensor anymore – just the XXXXXXX. Is there any attempt to make the 670g system communicate with the XXXXXX?
Terry, we’re always looking at ways to meet customers where ever they are on their diabetes journey. While we don’t have any information available at this time to share, we look forward to updating customers with information on our future innovations. We hope you’ll stay tuned.
when will it be available for Iphones?
Hi, there. The Guardian Connect is available on both iPhone and Android. Click here for a list of compatible devices:http://bit.ly/2lIi4jq
Two years and still no 670g remote monitoring? Theres a lot that can be done in two years. Is it really that hard to adapt your existing technology of the receiver from a pump, and create a bluetooth relay to send it to a phone?
Al, if it was only the transmitter that needed the Bluetooth capability it’d be easier. We need to make sure the pump, transmitter, and meter all seamlessly and safely work together for this connectivity. The transmitter is the first step so we’re excited to have this product done.
Well, I rushed to the Google play store and installed. Not compatible with my device. A OnePlus 7t ringing Android 10. Barely 7 months old. Do we know what the app is compatible with?
Jim, you can find a full list of compatible devices here: http://bit.ly/2lIi4jq We will be working on making more devices compatible and hope you stay tuned for details.
So after waiting over 2 years for the android app to finally be released in the US i can now download it from google play. Too bad the app doesn’t work on either my Samsung Note 9 or my S20. Others have posted similar experiences. Did they actually test this app?
I’m sorry you’re disappointed, Dan. We’re working on adding additional compatibility. I do see that we do have compatibility with S20s, but you can see a full list of compatible devices here: http://bit.ly/2lIi4jq
Is this what we have been waiting for?
http://newsroom.medtronic.com/news-releases/news-release-details/medtronic-guardiantm-connect-continuous-glucose-monitoring-cgm
yes!
Since we are still not able to use the 670g with the mini med connect what would be the possibility for us who have the pump to be able to use the Sugar IQ app with the information we upload to care link?
Thanks for reaching out, Athena. The Guardian Connect CGM system featuring Sugar.IQ is a tool that helps people on multiple daily injection therapy better manage their diabetes by providing predictive insights and helpful information about behaviors that might be impacting glucose levels. This system is not designed to be compatible with the MiniMed 670G system because while that system also provides predictive alerts, it automatically makes adjustments for you to help keep glucose levels in range. The pump essentially takes on much of the manual work whereas the Guardian Connect CGM system provides information and insights to help users make their own adjustments. We hope this helps – let us know if you have additional questions or suggestions about the technology!
Medtronic has been saying “Android coming soon” and “we’re working on it” for YEARS. I found an article from 2015. Still, CGM only working with iOS.
I no longer believe you. I have gone the entire lifespan of my current pump waiting. I will be looking into alternatives to Medtronic. I know that there others who have CGM’s that work with Android
I have been diabetic for thirty-eight years and a Minimed pump user for sixteen years. Over those past sixteen years I have had nothing but praise and accolades for Medtronic and it’s insulin pumps. I love my Minimed 670G system and am a loyal customer. As a loyal customer I would like to point out to Medtronic that as of February of 2020 Android accounts for 73.3% of the mobile global market. I am confused as to why Medtronic is overlooking the majority and focusing on a 26% market. On behalf of that 73.3% (and I have absolutely no intention of purchasing an iPhone) please give us a timeline as to an Android app for the 670G. Surely after a year and nine months if there is any real intention of developing this technology for Android there would be a finished product or at least some focused information that can be provided. Thank you for any specific details about where you are in the process.
Thank you for being such a loyal customer, Larry! We know it’s important for our users to have access to their data on different types of devices. Apple has strict control over their hardware and software releases. Android phone manufacturers routinely modify the operating system to best suit their devices, (for ex: the Samsung version can differ slightly to the LG version) which makes validation more complex. We’re still going to make Guardian Connect compatible with Android, of course, this is just why we chose to do iOS first. The FDA prohibits us from sharing details until approval, but we hope you stay tuned for updates.
Regarding Android: Even an update as to when they might plan to say when it’s available would be great. Q2 2020 etc. Just some sort of expectation would be great other than it’s the “top priority”. The team working on this must have some sort of timeline.
It really feels like a lack of transparency when customers keep asking for over a year and get absolutely nothing for an answer.
Also, is there an opportunity to be part of the beta. I would love to help out with the development process.
I understand the frustration, James. Due to FDA guidelines, we’re unable to share additional information on unapproved products. Timelines are based on several factors, including FDA approval. We will share updates as soon as they are available.
So 9 months and still no feedback? Has anything been submitted to the FDA. Is this actually being worked on? I am definitely seeing other companies doing this much, much better than Medtronic in that they have actually announced they were working on it and delivered a product. I have been using Minimed/Medtronic pumps since 1999. I am seriously considering another company at this point because they are able to meet this need while medtronic doesn’t even want to provide any transparency regarding this at all. We don’t even know if it was submitted to the FDA. Hoping for something in this area as we have been asking for an update for at least 2 years at this point. Way to long for any project. We seem to be able to get plenty of updates on COVID vaccines and what stage of the trials they are in. Can that be provided?
Jim, our Guardian Connect for Android has been approved and released. You can find it on the Google Play store.
Any updates on the FDA approval of the Bluetooth app 4 monitoring the 670g insulin pump?
Not at this time, Mike. As soon as updates are available, we’ll share them with our community. We hope you’ll stay tuned.
Any news on the Android app? Getting real tired of waiting, been well over a year now of this being “top priority” which clearly it’s not. I’ll have to look in to competitors when I get to choose a new pump next year, this is ridiculous. It’s very important to me I can have this data on my phone/smartwatch and I am not getting an iPhone.
I certainly understand the frustration, Joy. Unfortunately, there is still not an update available, we are committed to seeing this through and expanding access for our customers interested in our Guardian Connect.
I have been on a mini med pump since 1988 I was 17 when I got it. I got diabetes at age 4. When the cgm system first came out I tried it and it was so off with my true numbers so I stopped using it. Then came the new and improved version so I tried again and it would say I was 383 and in auto mode it would give me more insulin but when I checked I was 91 this was happening all the time and I was having seizures from getting to much insulin. I took it out of auto mode and I still had the issues of over a 100 point difference and the alarms going off all the time I got no good sleep from it. I have stopped all together using the cgm I am sad because when it would be in normal range it was great. I have been a diabetic for 42 years and do not feel me lows or highs any longer. I was let go from my job because due to having the high and lows and missing work I was with the company for 8 years when they let me go I loved what I did. Will there ever be a system that doesn’t have the big swing from what the cgm says to what a finger poke says? Or have I had a pump for so long and have to much scar tissue to get an accurate reading on the cgm. I know it will not be always the same reading as a blood test but 2 to 3 hundred marks off for me it is pointless to pay for the needles to use a cgm.
Thank you for sharing your experience with us and our community, Hollie. I’m very sorry to hear about your concerns, but we’d like to see if there is anything we can do to help. Our 24-Hour Technical Support team is available 24 hours a day, 7 days a week and are best able to talk through these types of concerns. If you’re interested in revisiting your CGM, please send us an email to dhelp@medtronic.com, with a copy of this comment and your contact information and we’ll be in touch.
It is now June 18th 2019 and I’m wondering if you have any idea of a projected date that the FDA will approve the Bluetooth app 4 monitoring the 670g insulin pump? I am sending this again as I don’t think it had my name or email attached.
Thanks for checking in, David. Unfortunately, there is still no update. FDA guidelines prevent us from discussing products until they have been approved. We know how important this is and will be sure to share updates as soon as they are available.
We have just been approved for the guardian connect sensor through the NDSS in Australia.
I specifically purchased a Samsung A5 android phone with Android 8 operating system because your website says it is compatible. Well the app does not work at all, just shuts down immediately. Am not happy.
Why introduce a system in Australia when half the population use android as opposed to Apple !
Dont get me wrong, the sensor is great, but I am now going to have to outlay more money to buy an apple phone for my husband who has vision problems and has never used an iPhone.
I thin’ yi7 should make it a top priority to update the app for Android since introducing it into Australia.
Sabine, I apologize for the delay in replying. You have reached the US team, but our teammates in Australia would be happy to answer any questions you may have. We understand how important viewing your data is and please know our teams are hard at work on Android compatibility and look forward to sharing updates.
Can the 670G pump handle bluetooth transmitting?
I read that you are working on new systems that can communicate with smartphones.
But is it possible to use the current 670G system?
Or do you have to release a new version of a pump?
For example 680G?
Hi, Roger. We are currently working on remote monitoring features for our insulin pump systems, but due to FDA regulations, we cannot share any info until it’s been approved. We look forward to sharing updates with our community as they become available.
Nicole. I upgraded to the 670g with the guardian 3 system with all of the hype of the benefits as well as all of the hype along side the Sugar.IQ and guardian connect… those were all buying points. To find out that they don’t actually work together and to include how much insurance is actually making my pay versus what I was initially told has left me feeling stuck with a disappointing system and trapped paying way more than I believe it’s worth… I am actually a user experience professional… to cut through and hopefully compromise is there any way I could be involved in a beta testing program for a compatible app and provide feedback and maybe help boost its release? I mean you and Kari Hawbaker have been saying that they’ve been working on this functionality for years. You have to have beta testers by now, right?
Hi there, Tad. I’m sorry for any confusion this has caused, as Guardian Connect and Sugar.IQ are not supported with our insulin pump systems. As far as beta testing and clinical trials, participants are selected by healthcare providers who are part of the clinical trial programs. Since our products are medical software related, traditional beta testing isn’t available. In the meantime, if you’d like to share your feedback and thoughts for improvement, please send us an email at dhelp@medtronic.com and we’ll share them with our development team.
Any timeline for when the Android version is going to be up and running?
Not yet, James. As soon as updates are available, we’ll be sure to let our community know.
Am I to understand, I have no way to check what’s happening with the guardian link 3 with out the app that’s only available for apple users ? How does it work with the 670g ? I committed out of pocket for 3 boxes of the sensors. Have I be offered a system that I can’t use ? Why is this being sold if it can’t be used ?
Thanks for reaching out, Brent. Our Guardian Link 3 transmitter is designed to work with our MiniMed 670G system and sensor data is displayed directly on the pump. Our Guardian Connect transmitter powers our Guardian Connect CGM only system and is not compatible with our pump systems. These transmitters include different internal components and are not the same. I hope this clears up any confusion, but if you have additional questions, please give our 24-Hour Technical Support team a call at 800.646.4633, option 1.
Any update on when 670g users can use the apps?
Not at this time, Kimberly. Once updates are approved by the FDA, we’ll be sure to share more information with our community.
Will owners of the new 670g have to wait or upgrade to have the systems info available on iPhone or Apple Watch
I would be disappointed to have to outlay more money for an addition that would improve userbility of this system greatly
The best would be to combine the guardian connect with the 670g and or allow them to be used together, please guys can you make this happen and if you do I guarantee there will be a lot of happy diabetics everywhere
Great questions, Cameron. Unfortunately, without approval for any feature enhancements or devices, I don’t have any information on exchange or upgrade programs that may be offered. We’ll share updates with our community as they become available.
I would like to know more about that warning about not using the 670G for children under age 7. My son is 4. He is using the 670G. Is this warning more alluding to Automode use? Because that was dangerous on him, but we are not seeing any dangers on Manual Mode? Should I be concerned?
Beth, we’ve performed an evaluation of the MiniMed 670G system and determined it may not be safe for those 7 years of age and younger, or anyone who require less than 8 units of insulin a day. We encourage you to reach out to your son’s healthcare team with any questions regarding his therapy needs.
I have a teen that has recently switched to the MiniMed closed loop from the Dexacom cGM/ Animia pump. The one thing I loved about dexacom was being able to see what his cGM BG was while I was at work or he was out with friends. My phone would alarm with a screaming baby if he was below 60. The fear of every parent of a type 1 is they will go low, go unconscious and never wake up. Like most teens he rolls his eyes when I ask why his pump is alarming or what his BG is and he tends to silence or ignore the alarms esp if he is high. Please get something like it for your system. It will allow parents like me to not hover over their type 1 teen and the teen will be able to safely do what other kids do.
Jasmine, we can certainly understand parents and other caregivers wanting to keep an eye on their loved ones through remote monitoring. At this time, our pumps do not have this option, but we know how important this is to our community and we are working on this feature for our pumps. In the meantime, we hope SmartGuard Auto Mode is providing some peace of mind by keeping him in range. We will be sure to update our community as soon as possible.
Is the Guardian Connect app compatible with the CGM associated with the 670G system?
Hi there, Kristen. At this time, the Guardian Connect app is only compatible with our Guardian Connect CGM only system. We look forward to adding similar features to our insulin pump systems in the future. We’ll share more information as we can.
The lack of compatibility with Android means I should have purchased a different system than the 670. I can’t believe I didn’t do that basic due diligence before pulling the trigger. So do I buy an iphone or pay out of pocket for a Dexcom? Pretty easy choice.
I’m sorry you are disappointed, Brian. While our Guardian Connect CGM is currently compatible with an Apple device running iOS 9.3 and above, we understand the need for android compatibility. In additions, at this time, our MiniMed 670G system does not offer remote monitoring features. Please know we are working on these and other innovative features and look forward to sharing updates with our community
Any update on the Bluetooth version of the 670g? We NEED the remote monitoring capability that I think that pump functionality will offer.
We understand how important these types of features are, Melissa, but at this time, we do not have a timeline to share. We’ll update our community as soon as we have more information available.
I’m also wondering when I will be able to check BG and dose from my glucometer? It is VERY inconvenient to check BG, then take my pump off my belt line and figure out/dose for my carbs. I had an Animas Ping and it was so much better being able to check, figure carbs and dose from my meter. I absolutely loved that component.
We appreciate you reaching our, Sharon and I’m sorry to hear your thoughts on your CGM. If you haven’t already, I certainly recommend speaking with our 24-Hour Technical Support team to discuss your concerns, as we’d like to see what we can do to help. As far as using your meter for additional features, our MiniMed 670G system does allow for remote bolusing when used in Manual Mode. If you’d like to learn more or discuss your options, our support team can help with this as well. You can reach them at 800.646.4633, option 1.
I started using MiniMed 670G in July of this year. I do like the pump but really, really, really don’t like CGMS. In fact, I’ve stopped using it. I was being woken up so much during the night with very different readings; beeping when I’m driving on road so I have to pull over to see what’s going on; and just all-in-all don’t like it.
Any update on Android compatibility? Karrie, your last response sounds like the team may be working on other projects? So you may want to remove this line from the above article, “Providing access for Android users is our first priority”, if it’s not actually the first priority.
Steven, while we are consistently working on new and innovative projects, we are still committed to providing Android compatibility. We understand the need to support multiple mobile device operating systems and are working on an Android version for Guardian Connect. Unfortunately, at this time we don’t have a timeline to share, but we will make sure to keep our community updated.
Hello, thought I would check-in on my post from 1 1/2 years ago. How does Medtronic define “first priority” because this delay feels like “last priority.”
Guardian Connect for Android has been approved and is available in the Google Play Store.
Thanks, I downloaded the app on my Samsung S20+. Alas, I keep receiving the “Transmitter Not Found.” Tried the recommended steps to no avail. Based on the Google Play store reviews, seems like many others are experiencing technical errors as well.
Steven, are you using our Guardian Connect CGM only system or one of our insulin pump systems? Keep in mind, our Guardian Connect app is only compatible with our Guardian Connect system.
Will this guardian connect app work with the G670 system? And what about the G660 system? My issue currently is that I can’t hear the sensor alerts when sleeping since my pump is covered by a duvet/blanket when sleeping and as such being able to place a mobile phone beside my pillow that can communicate with my pump and CGM would be a huge game changer for me. Also since it opens up for potential ringtone changes that the user may respond to if he/she is a heavy sleeper like me.
Puriya, thanks for your comments. Currently, our Guardian Connect app is only compatible with our Guardian Connect standalone smart CGM< but our teams are hard at work on similar features for our insulin pump systems. We look forward to sharing updates with our community as they are available.
Hello Ms. Hawbaker,
It has been two months since the last question about Android compatibility. Is there an available timeline for release yet? If not, can you inform if this is a team just for the Android app or do they have other responsibilities that could superced this task?
Hi, Joel. I still don’t have a timeline available. While our goal is to provide Android compatibility as soon as possible, it is possible that our teams may have other projects as well. We know how important this technology is and the value of reviewing data on the device of your choice. We look forward to sharing updates as soon as they are available.
“Providing access for Android users is our first priority.”
Any update on when this will be available?
Not at this time, Dan, but our team is still hard at work on making this available.
when will the application support android 8 being a android user it is a disadvantage. Also, the app on the play store is misleading as it does not mentions if it is compatible with devices under Android 8 or not.
Thanks for reaching out, Jha! Currently, our Guardian Connect and Sugar.IQ apps are not available for any Android devices. Our team is hard at work to make this available for as many customers as possible, but I do not have a timeline to share. I’ll be sure to share your feedback about the Google Play store with our teammate and of course once available, we’ll be sure to share updates with our community.
Sorry, but is it a possiblity that the Sugar IQ app will come to Europe?
We are working on expanding the availability of Sugar.IQ, but don’t have a timeline to share. Stay in touch with your local team for updates and more information.
I have Medicare as my only insurance. Now that the Guardian 3 CGM has been FDA approved, and the 670 G is already approved, what stands in the way for CMS/Medicare to approve the 670 G pump for those of us diabetics that are so labile that desperately need this upgrade. I have severe hypoglycemic unawareness. I have had blood sugars as low as 23 (unconscious), 31 & 36 over the last 6 weeks. My previous commercial insurance had no issue with Minimed and approving the enlite sensors when that was all that was available. What can I do now?
Barbara, we are pursuing Centers for Medicaid and Medicare Services (CMS) coverage, but at this time, we don’t have a timeline to share. In the meantime, if you’d like to discuss your options for ongoing sensors, please give us a call at 800.646.4633, option 2, to speak with our Supply team.
Medicare coverage of the 670G and Guardian sensor is crucial. Please send updates when you have them.
We certainly will, Pamela.
When will an advanced sensor system be available for those of us who require water therapy?
I’m not sure I understand. When the transmitter is connected to a sensor or the charger it forms a water-tight seal and waterproof in up to 8 feet of water for up to 30 minutes. If you still have additional questions about our products, please send your contact information to dhelp@medtronic.com and we’ll connect you with a teammate who can help.
I need insulin pump therapy ..
I have one , but it’s broken … how can I buy a new one ?!!
Abdulaziz, our device specialist would love to chat with you to discuss your options. Give us a call directly at 800.646.4633, option 3 to speak with a teammate.
Hi.
We have 670C and Guardian Sensor which working together. Can we use these apps too?
Erol, we’ve heard how important remote monitoring is for those who have chosen automated insulin delivery (i.e. the MiniMed 670G system) and our teams are hard at work on making this available. The Guardian Connect system is a key milestone to providing Bluetooth connectivity and smartphone access to customers using our insulin delivery systems. With Bluetooth-enabled CGM, we have one of the key components for the system, and we’re working hard to connect our insulin pumps and meters via Bluetooth as well. As we have an update we’ll let the community know. We’re also working on improvements to the system and expanding access for those interested in automated insulin delivery systems.
Started using the 670G on Tuesday, Nov. 29th. I also found out that my old uploader the worked with my 530 does not work which is very disappointing.
It would show my glucose levels on my iPhone and text my wife when I got low which has saved my life more than once. It would bluetooth my glucose levels to carelink without hooking my meter to my computer. I would have thought that medtronic would have made it so my uploader still worked.
Sorry I’m confused with the 670g with cgm can the cgm be connected to a mobile device? But not the pump? I’m a mother of T1D and we just started the 670g with cgm and I want to know if there is anyway to monitor her at night??
Melissa, the CGM portion of the MiniMed 670G system does not have remote monitoring capabilities at this time. Our Guardian Connect is a standalone CGM and uses a different transmitter than on insulin pump systems. Our community has made it clear how important these features are and we are working on them. I don’t have a timeline available to share, but we’ll be sure to keep our community updated.
Is there any update on this?
Not yet, Caryn. The FDA limits the amount of information we can share, but we are very committed to seeing this feature through.
Do you have any update on this process? This would be so helpful & give our family peace of mind.
Christine, what questions can we answer for you?
Hi Nicole,
I searched around the website but couldn’t find any updates so far. Have there been any developments Regarding the 670G system’s compatibility with the connect sensor for smartphones?
Thanks,
Daniel
Not at this time, Daniel. We’ll share updates on new/enhanced technology with our community once available.